alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE> 5

<LEGEND>
The schedule contains summary financial information extracted from the
consolidated financial statements and is qualified in its entirety by
reference to such financial statements.
</LEGEND>

<MULTIPLIER> 1

       
<S>                                            <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              JUN-30-1998
<PERIOD-START>                                 JUL-01-1997
<PERIOD-END>                                   MAR-31-1998
<CASH>                                           3,161,909
<SECURITIES>                                     8,361,207
<RECEIVABLES>                                    5,174,897
<ALLOWANCES>                                       106,118
<INVENTORY>                                      3,101,754
<CURRENT-ASSETS>                                20,337,828
<PP&E>                                           3,009,184
<DEPRECIATION>                                   1,786,666
<TOTAL-ASSETS>                                  22,050,214
<CURRENT-LIABILITIES>                            4,170,818
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                            56,776
<OTHER-SE>                                      16,755,915
<TOTAL-LIABILITY-AND-EQUITY>                    22,050,214
<SALES>                                         17,353,978
<TOTAL-REVENUES>                                17,353,978
<CGS>                                            8,105,262
<TOTAL-COSTS>                                   14,091,139
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                  36,099
<INCOME-PRETAX>                                  3,999,423
<INCOME-TAX>                                     1,112,803
<INCOME-CONTINUING>                                      0
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                     2,886,620
<EPS-PRIMARY>                                          .51
<EPS-DILUTED>                                          .43
        


</TABLE>
October 17, 2000

22973

#### State v. Benitez

Affirmed
EXHIBIT 23


                        CONSENT OF INDEPENDENT ACCOUNTANT


         We consent to the incorporation by reference in the registration
statements of Interneuron Pharmaceuticals, Inc. on Form S-8 (File Nos. 33-58742,
33-76652, 33-94730, 33-94736 and 333-40315) and on Form S-3 (33-75826, 333-1273
and 333-18001) of our report dated December 18, 1997 on our audits of the
consolidated financial statements of Interneuron Pharmaceuticals, Inc. as of
September 30, 1997 and 1996 and for each of the three years in the period ended
September 30, 1997, which report is included in the Annual Report on Form 10-K
of Interneuron Pharmaceuticals, Inc. for the fiscal year ended September 30,
1997.


                                                     Coopers & Lybrand L.L.P.

Boston, Massachusetts
December   29, 1997
IV 

114TH CONGRESS 

1ST SESSION H. RES. 314 

Expressing the sense of the House of Representatives regarding the eligibility 

of veterans service organizations for community development block grant 

funding. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 12, 2015 

Mr. FRELINGHUYSEN submitted the following resolution; which was referred 

to the Committee on Veterans’ Affairs, and in addition to the Committee 

on Financial Services, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

RESOLUTION 

Expressing the sense of the House of Representatives regarding the eligibility of veterans service organizations for 

community development block grant funding. 

Whereas the Veterans of Foreign Wars, the American Legion, and other veterans service organizations, through 

local posts, provide a host of invaluable services to veterans across the United States, including benefits assistance, career services, financial assistance, homeless outreach, and supporting services; 

Whereas veteran service organizations also provide several 

important services for local communities, including varVerDate Sep 11 2014 23:37 Jun 12, 2015 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR314.IH HR314

smartinez on DSK4TPTVN1PROD with BILLS
2 

•HRES 314 IH 

ious educational programs, and providing shelter during 

public emergencies; and 

Whereas notwithstanding the critical services provided by veteran service organizations to veterans and the public, 

some posts may be deemed ineligible for Federal community development block grant funding for public facilities 

and improvements; Now, therefore, be it— 

1 Resolved, That it is the sense of the House of Rep2 resentatives that— 

3 (1) veterans service organizations provide in4 valuable services to the veterans and local commu5 nities across the United States; and 

6 (2) Congress should seek changes to Federal 

7 law to ensure that all veteran service organizations 

8 are eligible for community development block grant 

9 funding for public facilities and improvements fund10 ing. 

Æ 


smartinez on DSK4TPTVN1PROD with BILLS
<PAGE>

                   CENTENNIAL CELLULAR CORP. AND SUBSIDIARIES
                              EXHIBIT TO FORM 10-Q

                   For the Six Months Ended November 30, 1996

                      COMPUTATION OF LOSS PER COMMON SHARE
                  (Amounts in thousands, except per share data)

<TABLE>
<CAPTION>

                                                                 Six Months Ended
                                                      --------------------------------------
                                                        November 30,           November 30,
                                                            1996                   1995
                                                      --------------          --------------
                                                                    (Unaudited)

<S>                                                <C>                    <C>
Primary fully diluted:
Net Loss                                              $     (12,228)          $    (10,767)
Accretion in liquidation value of preferred stock            (7,723)                (6,688)
                                                      -------------           ------------ 
Loss applicable to common shares                      $     (19,951)          $    (17,455)
                                                      =============           ============ 

Average number of common shares and common
      share equivalents outstanding
         Average number of common shares
         outstanding during this period                  26,932,000             26,386,000
        Add common share equivalents - Options
         to purchase common shares - net                    120,000                570,000
Average number of common shares and common
      share equivalents outstanding                      27,052,000 (A)         26,956,000(A)
                                                      =============           ============ 

Loss per common share                                 $        (.74)(A)       $       (.65)(A)
                                                      =============           ============ 
</TABLE>


(A)      In accordance with Accounting Principles Board Opinion No. 15, the
         inclusioin of common share equivalents in the computation of earnings
         per share need not be considered if the reduction of earnings per share
         is less than 3% or the effect is anti-dilutive. Therefore, loss per
         common share equivalents as shown on the Consolidated Statements of
         Operations for the periods presented do not include certain common
         share equivalents as their effect is anti-dilutive. However, the
         consolidated financial statements for the six month periods ended
         November 30, 1996 and November 30, 1995 do include the effect, on a
         retroactive basis of 0 and 385,631, respectively, of option shares
         issued prior to the Company's initial offering.



<PAGE>
Foreign Animal Disease 

Diagnostic Laboratory All calls to Laboratory Main Line: (631) 323-3256

African Swine Fever

Bluetongue /Epizootic Hemorrhagic Disease **

Classical Swine Fever

Foot and Mouth Disease and other vesicular 

 diseases of livestock 

Rabbit Hemorrhagic Disease

** If suspect Foot and Mouth Disease, samples

must go to FADDL. Please contact the laboratory 

at (631) 323-3256 prior to shipment.

Diagnostic Bacteriology 

Laboratory Laboratory Main Line: (515) 337-7568

(515) 337-7565

General Bacteriology

Contagious Equine 

Metritis

Leptospira

Salmonella

(515) 337-7563

Brucella (serology)

Piroplasmosis

Stat-Pak: 

 Tuberculosis

 serology

(515) 337-7388

Brucella (culture)

Johne’s

Mycobacterium

Tuberculosis (culture)

(515) 337-7181

Brucella Reagents

Johne’s Reagents

Tuberculosis Reagents

Pathobiology Laboratory Laboratory Main Line: (515) 337-7526

(515) 337-7920

Bovine Spongiform 

Encephalopathy

Chronic Wasting 

Disease

Scrapie

(515) 337-7065

Chemistry (Pesticides)

Fraudulent Blood

(515) 337-7526

Parasitology/

 Entomology

(515) 337-7912

Tuberculosis 

 (histopathology)

USDA – APHIS – NVSL

Attn: Foreign Animal Disease Diagnostic Laboratory

40550 Route 25

Orient, NY 11957

Ph: (631) 323-3256

Our regular business hours are 

8:00 a.m. - 4:30 p.m. CST for Ames 

laboratories and 8:30 a.m. - 4:15 

p.m. EST for the Foreign Animal 

Disease Diagnostic Laboratory 

(FADDL). Laboratory main lines are 

answered during regular business 

hours. Visit our website: http://www.aphis.usda.gov/animal_health/lab_info_services/ 

National Veterinary Services Laboratories Contact Information Updated April 2013

Diagnostic Virology 

Laboratory All calls to Laboratory Main Line: (515) 337-7551

(Testing + Reagents)

Aquatic animal diseases

Avian influenza

Bluetongue /Epizootic Hemorrhagic Disease **

Equine Arboviral Encephalitis 

 (Eastern, Western Venezuelan equine 

 encephalomyelitis & West Nile)

Equine Infectious Anemia (EIA) 

Equine Rhinopneumonitis(equine herpesvirus)

Equine Viral Arteritis

Malignant catarrhal fever

Newcastle Disease

Porcine Reproductive and Respiratory Syndrome

Pseudorabies

Swine influenza

Vesicular Stomatitis **

USDA – APHIS – NVSL

Attn: Sample Processing Department

1920 Dayton Ave.

Ames, IA 50010

Ph: (515) 337-7514 

NVSL Ames-Main Line (515) 337-7266

 (answered 24/7)

NVSL FADDL-Main Line (631) 323-3256

FADDL After Hours Emergency Contacts 

(631) 375-5314 or (631) 332-6814

Director’s Office (515) 337-7301

NAHLN Program Office (515) 337-7731

Case Coordinator (515) 337-7514

User Fees (515) 337-6200
```

[Federal Register Volume 79, Number 98 (Wednesday, May 21, 2014)]
[Notices]
[Page 29261]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11774]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Twenty Fourth Meeting: RTCA Special Committee 216, Aeronautical 
Systems Security

AGENCY: Federal Aviation Administration (FAA), U.S. Department of 
Transportation (DOT).

ACTION: Meeting Notice of RTCA Special Committee 216, Aeronautical 
Systems Security.

-----------------------------------------------------------------------

SUMMARY: The FAA is issuing this notice to advise the public of the 
twenty fourth meeting of RTCA Special Committee 216, Aeronautical 
Systems Security.

DATES: The meeting will be held June 13, 2014 from 9:00 a.m.-12:00 p.m.

ADDRESSES: The meeting will be held at RTCA Headquarters, 1150 18th 
Street NW., Suite 450, Washington, DC 20036.

FOR FURTHER INFORMATION CONTACT: You may contact the RTCA Secretariat, 
1150 18th Street NW., Suite 910, Washington, DC 20036, or by telephone 
at (202) 833-9339, fax at (202) 833-9434, or Web site http://www.rtca.org for directions.

SUPPLEMENTARY INFORMATION: Pursuant to section 10(a)(2) of the Federal 
Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.), notice is 
hereby given for a meeting of Special Committee 216.

June 13

 Open Meeting and Introductions
 Approve Summary--Meeting 23, RTCA Paper No. 107-14/
SC216-051
 Summarize FAA 5 Year Plan Meeting Discussion
 Status of Revised DO-326A--Airworthiness Security Process 
Specification and new document--Information Security Guidance for 
Continuing Airworthiness, and upcoming PMC Review
 Summary of DO-yy3--Security Assurance and Assessment Methods 
for Safety-related Aircraft Systems Comment Disposition
 Discussion of Consensus to Move DO-yy3--Security Assurance and 
Assessment Methods for Safety-related Aircraft Systems to Formal Review 
And Comment (FRAC) Period.
 12:00pm Close Meeting

    Attendance is open to the interested public but limited to space 
availability. With the approval of the chairman, members of the public 
may present oral statements at the meeting. Persons wishing to present 
statements or obtain information should contact the person listed in 
the FOR FURTHER INFORMATION CONTACT section. Members of the public may 
present a written statement to the committee at any time.

    Issued in Washington, DC, on May 15, 2014.
Mohannad Dawoud,
Management Analyst, NextGen, Business Operations Group, Federal 
Aviation Administration.
[FR Doc. 2014-11774 Filed 5-20-14; 8:45 am]
BILLING CODE 4910-13-P
```
# Interim Performance Report

An Interim Performance Report must be received within 90 days after the end of the first year of the date of the signed grant agreement and 90 days after the end of each subsequent year until the expiration date of the grant period. Interim Performance Reports must illustrate the progress made toward the completion of each project within the grant agreement. 

# Grant Information

## Agreement

## Recipient

## Report

# Performance Narrative

## Activities Performed

Address the below sections as they relate to this reporting period.

### Accomplishments

List your accomplishments for this reporting period and indicate how these accomplishments assist in the fulfillment of your project’s objective(s), outcome(s), and/or indicator(s). This listing should identify your project’s partners and their contributions.

### Challenges and Developments

Provide any challenges to the completion of your project or any positive developments outside of the project’s original intent that you experienced during this reporting period. If those challenges or developments resulted or will result in corrective actions and/or changes to the project, include those in the space below.

### Outcome and Indicator Results to Date

Quantify the overall progress on the outcomes and indictors of your project.

### Discussion of Results

If necessary, include further explanation of the quantifiable results to date.

## Upcoming Activities

Provide a description of the activities that you are planning to complete during the next reporting period.

## Project Expenditures to Date

### Expenditures

### Program Income (if applicable)

Page | 1
Breadcrumb

1. Home

2. Print 

3. Pdf 

4. Node 

5. Entity Print 

Aquatic Animal Export Resources

Last Modified: 

Print

Review the resources below for more information on aquatic animal exports,

including the APHIS-Registered Aquaculture Export Facility Inspection Program

(RAEF), disease sampling and testing guidance, and VS Form 17-141.
APHIS-Registered Aquaculture Export Facility

(RAEF) Inspection Program 

APHIS approval of an aquatic animal facility through the APHIS-Registered

Aquaculture Export Facility (RAEF) inspection program may be required prior to the

export of live aquatic animals to certain destination countries. As a reminder, RAEF

is only required if the facility is exporting to a country that either 1) requires APHIS

oversight (regardless of whether export testing is required or not), and/or 2) when

premises freedom level testing is required to export to a country. This section

provides more information and step-by-step guides.

Learn More About the RAEF Inspection Program

Disease Sampling and Testing Information 

Testing of live aquatic animals prior to export may be required for some countries.

This section provides guidance on the types of laboratories, level of testing, and

common aquatic animal pathogens.

Learn More About Disease Sampling and Testing

Health Certificate for Exporting Live Finfish,

Mollusks, and Crustaceans (and their Gametes)

Use VS Form 17-141 when the importing country requires it, or in cases where there

is not a country-specific export health certificate posted to the APHIS IRegs.

Instructions for Completing VS Form 17-141 (372.45 KB)

VS Form 17-141 (Fillable PDF) (249.52 KB)
_________________________________________ 

 

 

Order Michigan Supreme Court

Lansing, Michigan 

December 28, 2006 Clifford W. Taylor,

 Chief Justice 

131897 Michael F. Cavanagh 

Elizabeth A. Weaver 

Marilyn Kelly 

Maura D. Corrigan 

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee, 

Robert P. Young, Jr. 

Stephen J. Markman,

 Justices 

v SC: 131897 

 COA: 269403 

Kent CC: 04-005780-FH 

RUBEN ALLEN HOGUE,

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the June 29, 2006 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the questions presented should be reviewed by this Court. 

t1218 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

December 28, 2006 

 Clerk
Exhibit 10.1


 


EQUITY TRANSFER AGREEMENT


 


 


 


Transferors:


Zhao Zhen Rong(ID card No.110108194008173417)


Sun Gui Ying (ID card No.110108194306073422)


 


 


Transferee: OZOP (Guangdong) Medical Technology
Co. Ltd


 


 


1.The Transferors agree to transfer the
entire (100%) equity in Yijingtong (Beijing) Technology Development Ltd (The “Company”) (hereinafter referred
to as “Transferred Equity”) to the Transferee for RMB one million yuan. The Transferee agrees to buy the Transferred
Equity. The respective transfer prices of the Transferred Equity paid to the Transferors are listed below.


 


	Transferor	Transferred Equity	Transfer Price(RMB)
	Zhao Zhen Rong	80%	800,000
	Sun Gui Ying	20%	200,000


 


 


2.The Transferee shall pay to the Transferors
the transfer price within 120 days from the date of signing this Agreement.


 


3.If the Transferee fails to pay one million
yuan to the Transferors within 180 days, the Transferor shall have the right to terminate this Agreement and require the transferee
to return all the Transferred Equity.


 


4.The Transferors agree to transfer all the
inventory valued at RMB 4,072,719.4 million of the Company to the Transferee. The payment and delivery terms will be negotiated
by the parties separately.


 


5.The Transferors promise that they are the
sole owners of the Transferred Equity.


 


6.The Transferors undertake to pay the transfer
price according to Article 2 of this Agreement.


 


7.The Transferee and the Transferors shall
go through the change registration procedure with the industrial and commercial bureau immediately after signing this agreement.


 


8.If either party breaches this agreement,
the non-breaching party shall have the right to request termination of this agreement and claim compensation from the breaching
party for all economic losses.


 


9.The Parties shall solve any dispute or claim
arising from or relating to this Agreement through negotiation. If the Parties fail to reach an agreement after negotiation, the
Parties agrees to file a lawsuit with the People's Court at the place where this Agreement is signed.


 


10.This Agreement shall come into effect upon
execution by the Parties.


 


11.The conclusion, validity, explanation, implementation
and dispute resolutions shall be governed by the PRC law.


 


12.This Agreement has three copies, each of
which has the same legal force.


 


 


 


 


 




    	 



    	 



    

 


 


 


Transferors:


 


/s/ Zhao Zhen Rong


 


Zhao Zhen Rong


 


/s/ Sun Gui Ying


 


Sun Gui Ying 


 


 


 


 


Transferee: OZOP (Guangdong) Medical Technology
Co. Ltd


 


 


 


/s/ Eric Siu


 


Authorized Representative


 


 


Date of Signature: 23rd July, 2018


 


Where the contract is signed: Beijing
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 15-2258

BETTE J.T. JONES,

 Plaintiff – Appellant,

v.

NORTH CAROLINA DEPARTMENT OF TRANSPORTATION,

 Defendant - Appellee.

Appeal from the United States District Court for the Western 

District of North Carolina, at Charlotte. Graham C. Mullen, 

Senior District Judge. (3:15-cv-00170-GCM)

Submitted: April 21, 2016 Decided: April 25, 2016

Before WILKINSON, KING, and KEENAN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Bette J.T. Jones, Appellant Pro Se. Kenneth Andrew Sack, NORTH 

CAROLINA DEPARTMENT OF JUSTICE, Raleigh, North Carolina, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Bette J.T. Jones seeks to appeal the district court’s 

orders remanding her civil action to state court for further 

proceedings and denying her motions for reconsideration and for 

leave to file out of time. We dismiss the appeal for lack of 

jurisdiction because the notices of appeal were not timely 

filed.

Parties are accorded 30 days after the entry of the 

district court’s final judgment or order to note an appeal, Fed. 

R. App. P. 4(a)(1)(A), unless the district court extends the 

appeal period under Fed. R. App. P. 4(a)(5), or reopens the 

appeal period under Fed. R. App. P. 4(a)(6). “[T]he timely 

filing of a notice of appeal in a civil case is a jurisdictional 

requirement.” Bowles v. Russell, 551 U.S. 205, 214 (2007).

The district court’s final order denying reconsideration 

was entered on the docket on September 10, 2015. The notices of 

appeal were filed on October 15, 2015. Because Jones failed to 

file a timely notice of appeal or to obtain an extension or 

reopening of the appeal period, we dismiss the appeal. We deny 

Jones’ motion to supplement the record. We dispense with oral 

argument because the facts and legal contentions are adequately 
3

presented in the materials before this court and argument would 

not aid the decisional process.

DISMISSED
• 

EX PARTE 

SHANE MATTHEW NETTLES 

Petitioner~Shane Matthew 

respectfully request the 

cause. 

83, 61-0t 

WRIT NO. W09-00Z08-P(A)· 

§ I~ THE COURT~F'OF CRIMINAL APPEALS 

§ 

§ 

§ TRAVIS 

Grounds 

I. 

John 3:20,For everyone praticing wickedness.nhates the Light and does not 

come to the Light,that his works may not be exposed. 

II. 

John 3:21,But the one doing the truth comes to the Light,that his works mayQe 

revealed,that they exist,having been worked in ELOHIM. , 

Prayer!: 

Petitioner respectfully prays that this Court GRANT this motion and order 

this couse to bear the notation "PUBLISH" 

Executed on April 27, 2015* 

ORDER 

_Respectfully Silbm~;~' /~ ~·~ 

Bf: Shane nettles/~~ pet1tioner/Movant Pro Se 

On this* day of ;2015 came on to be heard Motion to Publish 

and it appears to the Court it should be GRANTED1DENIED. 

PRESIDING JUDGE 

C/C